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Abstract
Background: RNA-seq, a next-generation sequencing based method for transcriptome analysis, is rapidly emerging
as the method of choice for comprehensive transcript abundance estimation. The accuracy of RNA-seq can be
highly impacted by the purity of samples. A prominent, outstanding problem in RNA-seq is how to estimate
transcript abundances in heterogeneous tissues, where a sample is composed of more than one cell type and the
inhomogeneity can substantially confound the transcript abundance estimation of each individual cell type.
Although experimental methods have been proposed to dissect multiple distinct cell types, computationally
“deconvoluting” heterogeneous tissues provides an attractive alternative, since it keeps the tissue sample as well as
the subsequent molecular content yield intact.
Results: Here we propose a probabilistic model-based approach, Transcript Estimation from Mixed Tissue samples
(TEMT), to estimate the transcript abundances of each cell type of interest from RNA-seq data of heterogeneous
tissue samples. TEMT incorporates positional and sequence-specific biases, and its online EM algorithm only
requires a runtime proportional to the data size and a small constant memory. We test the proposed method on
both simulation data and recently released ENCODE data, and show that TEMT significantly outperforms current
state-of-the-art methods that do not take tissue heterogeneity into account. Currently, TEMT only resolves the
tissue heterogeneity resulting from two cell types, but it can be extended to handle tissue heterogeneity resulting
from multi cell types. TEMT is written in python, and is freely available at https://github.com/uci-cbcl/TEMT.
Conclusions: The probabilistic model-based approach proposed here provides a new method for analyzing RNA-
seq data from heterogeneous tissue samples. By applying the method to both simulation data and ENCODE data,
we show that explicitly accounting for tissue heterogeneity can significantly improve the accuracy of transcript
abundance estimation.
Background
The rapidly advancing next-generation sequencing based
transcriptome analysis tool, RNA-seq, provides a com-
prehensive and accurate method for analyzing the entire
RNA components of the transcriptome [1]. The effi-
ciency and sensitivity of RNA-seq make it a primary
method for detecting alternatively-spliced forms and
estimating their abundances [2,3]. However, estimating
transcript abundances in heterogeneous tissues by RNA-
seq remains an unsolved, outstanding problem because
of the confounding effect from different cell types [4].
Many tissue samples from native environments are het-
erogeneous. For example, tumor samples are usually
composed of tumor cells and surrounding normal cells
[5]. Therefore, reads from an RNA-seq experiment of
tumor samples will consist of contributions from both
tumor and normal cells. Additionally, tumor tissues
themselves are often heterogeneous, consisting of differ-
ent subclones (e.g. breast cancer subtypes [6]), leading
to even more complicated tissue environments.
Experimental methods have been proposed to address
issues arising from contamination of different cell types,
such as laser-capture microdissection [7], which allows
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dissection of morphologically distinguishable cell types.
The mRNA content yield by this technology is conse-
quently lowered, and needs to be compensated for,
usually by molecular amplification. However, the nonli-
nearity induced by amplifying mRNA [8] has its own
problems, and can make the expression profiles of dis-
tinct cell types less distinguishable, weakening the sensi-
tivity of RNA-seq technology. Other experimental
approaches, including cell purification and enrichment,
are comparatively expensive and laborious [9]. Therefore
developing alternative in silico approaches to resolving
the tissue heterogeneity problem, especially in cancer
research, remains a major problem in RNA-seq analysis
[10].
Research in computational approaches to resolving the
tissue heterogeneity problem of different biotechnologies
has a fairly long history [11-14]. The first attempt to
computationally micro-dissect heterogeneous tissues for
microarray expression data was based on a linear model
[11], which estimated both cell-type proportion and gene
expression level. Prior information regarding “marker
genes”, which are genes uniquely expressed in each cell-
type, was incorporated into the linear model to identify
distinct cell types. The linear model was extended with
Bayesian prior densities of cell-type proportions [13], and
a posterior sampling approach was then constructed for
cell-type-specific expression profiling. A statistical testing
method [14] was proposed for single nucleotide poly-
morphism (SNP) array based copy number alterations
analysis from heterogeneous tissue samples. In this
method, Bayesian differentiation between hemizygous
deletion and homozygous deletion were used to infer the
underlying normal cell proportion and copy number pro-
files of both normal cells and tumor cells. One common
feature shared by these methods is that they all adopted
probabilistic models, not only allowing prior information
about different cell types to be smoothly incorporated
into the models, but also taking advantages of the flex-
ibility of probabilistic model to capture specific aspects of
each data type.
To the best of our knowledge, no computational
approaches have been proposed to resolve the tissue het-
erogeneity problem from RNA-seq data in a probabilistic
fashion. Typically, researchers apply transcriptional pro-
filing tools designed for homogeneous tissue samples
directly to RNA-seq data from heterogeneous tissue sam-
ples. Subsequent estimation results are interpreted as
transcriptional profiling of a particular single cell type of
interest. Therefore, we ask whether it is possible to esti-
mate trancriptive abundances of individual cell types
from RNA-seq of heterogeneous tissues, by decoupling
the contributions from multiple cell types. We propose a
probabilistic model-based approach, Transcript Estima-
tion from Mixed Tissue samples (TEMT) to address this
question. Currently, TEMT requires two sets of single-
end RNA-seq reads. One read set is from a heteroge-
neous tissue sample composed of two cell types, while
the other is from a pure tissue sample composed of one
of the two cell types. TEMT incorporates prior informa-
tion of cell type proportion and can calculate probabil-
ities of RNA-seq reads sampled from each cell type.
Because TEMT implements an online EM algorithm
[15], it has a time requirement proportional to the data
size and a constant memory requirement. To further
improve the estimation accuracy, TEMT also implements
a bias module, which incorporates both positional bias
[16-18] and sequence-specific bias [19,20].
To assess the performance of TEMT, we analyzed a
series of both simulation and real data from ENCODE
[21], and compared the transcript relative abundances
estimation from TEMT to those obtained from other
methods that do not take the tissue heterogeneity into
account. Our results show that explicitly accounting for
tissue heterogeneity can significantly improve transcript
abundance estimation accuracy.
Methods
In this section, we first introduce the generative mixture
model of TEMT. Combined with cell type proportion as
prior information, we propose a maximum a posteriori
estimation approach for finding model parameters.
Next, we explain how to incorporate a positional and
sequence-specific bias module into the model. Finally,
we introduce an online EM algorithm for parameter
estimation, reducing the time complexity to be propor-




We focus on transcript abundance estimation. Denote T
as a set of reference transcripts, which we assume is
known and complete. Let lt denote the length of transcript
t in the set with t = 1, · · · ,T, where T is the total number
of transcripts in the reference set. Suppose we are inter-
ested in transcriptome analysis in two cell types: a and b.
Let ρat and ρbt denote the relative transcript abundance of
transcript t in cell type a and b, respectively, with










We assume RNA-seq reads are available in two samples:
one consisting of cells of only type a, which we call the
“pure sample”, and the other consisting of cells of both
type a and b with percentage T a from cell type a and T b
from cell type b, which we call the “mixed sample.” In the
cancer transcriptome analysis, cell type a can represent
normal cells as it is usually easy to obtain a pure tissue
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sample, while cell type b can represent tumor cells as most
tumor tissue samples are contaminated by normal cells.
Because the pure sample consists of only cell type a,





t for all t. However, the relative abundance of
transcript t within the mixed sample is a weighted sum







t = 1 (1)
Denote the read set from the pure sample by Rp and
the read set from the mixed sample by Rm. Our goal is
to estimate the relative abundance of each transcript in
the reference set T from the RNA-seq read data Rp and
Rm in both cell type a and b
Alignment representation
We first map reads to the reference transcript set T
and convert the raw read data into a correspond-
ing alignment representation. Denote the align-
ment representation of the read set Rp by Yp =
{ypi,t|i = 1, · · · , Np, t = 1, · · · , T}, where ypi,t = 1 if read i
from Rp aligns to transcript t and 0 otherwise, and Np is
the total number of reads in read set Rp. The alignment
representation Ym = {ymi,t|i = 1, · · · , Nm, t = 1, · · · , T} is
similarly defined for read set Rm from the mixed sample.
Note that one read might map to multiple transcripts due
to alternative splicing, sequence similarity shared by homo-
logous genes, or other reasons. As a result, the summation
of ypi,t over all transcripts may be bigger than 1 for some i.
These “ambiguous reads” introduce a major source of
uncertainty into transcript abundance estimation.
Generative model
We model the sequencing of reads as a sampling pro-
cess, randomly chooses a transcript t from the reference
transcript set T according to its relative abundance and
effective length, and then generates a read from a ran-
dom location of the chosen transcript. Under this








with s being either p for the pure sample or m for the
mixed sample. Here, l˜t is the effective length of tran-
script t, which quantifies the number of positions at
which a read can start within transcript t. Different
methods have been proposed to model the effective
length [19,22]. In TEMT, the effective length is modeled








(lt − x + 1) (3)
We assume the fragment length x has a normal distri-
bution with mean µ and variance σ 2, and φ(x;μ, σ 2) is
the normal probability density function of. By renorma-
lizing φ(x;μ, σ 2), we obtain the discrete distribution of
all possible fragment lengths. The effective length l˜t is
then the expectation of the number of positions a read
can start within transcript t, based on the discrete distri-
bution of fragment length.
Suppose a read is generated uniformly from each loca-
tion covered by the effective length of each transcript.
Then the probability of observing read i as represented








for s = p or m.
Assume each read is generated independently in both
the pure and the mixed samples. The likelihood of
observing the read set Rpfrom the pure sample and Rm
from the mixed sample is then described by


















We are interested in estimating the relative transcript
abundances set {ρat }Tt=1, {ρbt }Tt=1 but since it can be
uniquely defined by the read sampling probability set














We can directly estimate the read sampling probability
{αat }Tt=1, {αbt }Tt=1 set from the likelihood function Equation (5)
instead. Note that, again αpt = α
a
t for all t as it is the para-
meter of pure sample, but unlike the linear form in Equa-
tion (1), αmt in terms of αat ,α
b
t is given as a nonlinear form
αmt = 



















Where, the factor a,b induce the nonlinearity. But
due to the averaging effect of the large number of tran-
scripts, practically a,b lies within 1 ± 0:05. So we
approximate αmt with the linear form
αmt ≈ τ aαat + τ bαbt (9)
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As it brings computational convenience in the follow-
ing learning step.
Finally, we define
 = {{αat }Tt=1, {αbt }Tt=1, τ a, τ b} (10)
as the parameters of our model. The likelihood in


















Maximum a posteriori estimation
Several analysis have noticed the identifiability problem
[12,13] in estimating cell type specific expression in het-
erogeneous tissue samples. Ideally, if the proportion
information for some cell types is missing, we can then
pool these cell types as one type, making the expression
of each individual cell type inside unidentifiable. Pre-
viously, prior constraints have been used to resolve the
problem [12,13]. In our model, the prior knowledge of
cell type proportions is combined with the model likeli-
hood, and we subsequently use maximum a posteriori
(MAP) estimation to find the optimal parameters.
Specifically, we place a Beta (βa, βb) distribution as
the prior for cell proportions of type a and type b. The
parameter βa, βb quantify the location and sharpness of
the prior. Practically, we found setting βa, βb 10 times
as the data size gave a good convergence rate and accu-
racy. Combining the prior with the likelihood given in























Both positional [16-18] and sequence-specific [19,20]
sequencing biases have been observed in next generation
sequencing data. These biases mainly result from non-
uniformly distributed cDNA fragments during the RNA-
seq library preparation [20]. Under positional bias, reads
positioning is not uniformly distributed across the effec-
tive length of the target transcript, but preferentially dis-
tributed around either the 5’ end or the 3’ end of the
target transcript. Under sequence-specific bias, the
sequences near the two ends of the fragments affect
their probability to be sequenced. To account for these
non-uniformity effects during transcript abundance esti-
mation, we incorporate the bias module of [19] into our
model.
In order to further describe the local alignment con-
text, we define another two sets of variables. Specifically,
for read i from either read set Rp or Rm, we denote
bsi, t ∈ [0, l˜t] as the starting position of the alignment
within transcript t relative to the 5’ end of the strand.
We also denote π si, t ∈ L, where  = {A, C, G, T}, as
the local sequence of transcript t with length L and cen-




P(bsi, t|bias)P(π si, t|bias)
P(bsi, t|uniform)P(π si, t|uniform)
(13)
for s=p or m.
This bias weight wsi, t is essentially the ratio of the
probability of observing bsi, tand π
s
i, t under the bias
model to the probability under the uniform model. If no
bias exists, the weight wsi, t reduces to 1. The bias re-
weighted Equation (4) is then:







To calculate the bias weight, we use the bin method
and Markov chain for positional bias and sequence-spe-
cific bias respectively. Complete details can be found in
the Supplementary (Additional file 1). The final unnor-
























Where wpi, t and w
m
i, t are the bias weights computed
based on read set Rp and Rm. The directed graphical
model of TEMT is shown in Figure 1. The estimated




Online EM algorithm for learning
We solve the maximum a posteriori problem in Equation
(16) using the Expectation-Maximization (EM) [23] frame-
work. For each read i from read set Rp of pure sample, we
denote the latent variable of the transcript alignment
representation as Zpi = {zpi,t|t = 1, · · · , T}, where zpi,t = 1if
read i aligns to transcript t and 0 otherwise. But now
T∑
t=1
zpi,t = 1, which means only one z
p
i,t = 1, indicating read i
is actually originating from transcript t. Similarly, for each
read i from read set Rm of mixed sample, we denote the
latent variable of the transcript alignment representation
as Zmi = {zmai,t , zmbi,t |t = 1, · · · , T}, where zmai,t = 1 if read i
aligns to transcript t and is originating from cell type a
within the mixed sample, and 0 otherwise. zmbi,t = 1 or 0 is




i, t + z
mb
i, t ) = 1
means read i is actually originating from only one
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transcript, and either from cell type a or b within the
mixed sample. We also define the auxiliary variable
qmai, t = P(z
ma
i, t = 1|, Yp, Ym), qmai, t = P(zmai, t = 1|, Yp, Ym)
and qmbi, t = P(z
mb
i, t = 1|, Yp, Ym) as the conditional prob-
ability weight of each latent variable zpi, t = 1, z
ma
i, t = 1 and
zmbi, t = 1 conditional on model parameters Θ and the
observed read alignment representations YpYm. Then
based on Jensen’s inequality [24], the complete posterior
distribution, which is also the lower bound of Equation (15)
can be written as

























⎤⎦ (τ a)βa−1(τ b)βb−1 (17)
In which C is a normalizing constant and the equality
holds only if the conditional probabilities qpi, t, q
ma
i, t , q
mb
i, t






The EM framework maximizes Equation (17) by itera-
tively applying the expectation step and the maximiza-
tion step to update both the conditional probabilities
qmai, t , q
ma
i, t , q
mb
i, t and model parameters Θ until convergence.
The expectation step of typical batch EM algorithm has
to fetch all the data points into memory, and calculates
the conditional probabilities based on the average of all
the data points. While this batch method guarantee’s
the log-likelihood function to monotonically increase, it
also induces inefficiency in both time and space
complexity. Considering the high-throughput nature of
next-generation sequencing technology as well as its
huge data size, we implemented the EM algorithm in an
online fashion [15] to both lower the memory require-
ment and boost the convergence rate.
The main difference between the batch EM and the
online EM is in the E-step. The E-step of the online EM
algorithm first calculates the conditional probabilities of
only one new data point, and then updates the condi-
tional probabilities of all the current data points by inter-
polating between the conditional probabilities of all the
previous data points and the conditional probabilities of
the new data point, with a forgetting factor s controlling
the convergence rate.
It is shown in [15] that with the constraint 0.5 < s ≤ 1,
the online EM algorithm is asymptotically equivalent to
stochastic gradient ascent, and is guaranteed to converge
to the maximum likelihood estimator, which is extended
to the maximum a posteriori estimator in our model.



















Figure 1 The representative graphical model of TEMT.
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In Equation (18-20), we compute the conditional prob-




i+1, t of just one new read i + 1
based on previous parameter estimation {αa(n)t }Tt =1,
τ a(n), τ b(n), τ a(n), τ b(n); In Equation (21-23), we compute
the new conditional probabilities average qp(n+1)∗, t , q
ma(n+1)
∗, t ,
qmb(n+1)∗, t by interpolating between the previous conditional
probabilities average qp(n)∗, t , q
ma(n)
∗, t , q
mb(n)





qmbi+1, t. n is the index of iteration step and i is the index of
data points. s is the forgetting factor which controls the






































In the subsequent M-step, parameters {αa(n+1)t }Tt =1,
τ a(n+1), τ a(n+1), τ b(n+1) are updated according to new con-
ditional probabilities average qp(n+1)∗, t , q
ma(n+1)




Next we test the performance of the proposed method
on both simulation data and the recently released
ENCODE data [21]. For both datasets, we used the fol-
lowing three-step protocol and parameters to construct
the analysis:
1. We aligned the raw read set from either simulation
or the ENCODE data to a given transcript set using
bowtie-0.12.7 [25]. For each read, we allowed 2 mis-
matches and reported at most 10 candidate alignments.
2. The abundance of each transcript in terms of esti-
mated counts was estimated via both TEMT and a con-
trol model. Estimated counts is defined as the estimated
number of reads generated from the target transcript. In
TEMT, the prior of each cell type proportion was set to
the same as the proportion used in simulation and
ENCODE data respectively, and ba, bb was set to 10
times the size of the read set Rm. μ = 200; s = 80 were
used as the mean and standard deviation of the RNA-seq
fragment length distribution. We chose eXpress-0.9.4
[26] as the control model, as it is the state-of-the-art
method for transcript abundance estimation and also uti-
lizes an online-EM algorithm. Note that, to run TEMT,
we need two read sets, in which one is for the pure sam-
ple and the other is for the mixed sample, as previously
mentioned. In contrast, to run eXpress, we only need one
read set from either the pure sample or the mixed sam-
ple. The forgetting factor for the on-line EM algorithms
in both TEMT and eXpress was set to be s = 0:85, and
the error-model in eXpress was disabled for comparison.
3. To measure the model accuracy, we used the Error
Fraction (EF) measure introduced by [17] to quantify
the discrepancy between the model estimates and the
ground truth estimates. The Error Fraction is defined as
the fraction of transcripts for which the estimates are
significantly different (percent error >10% in our case)
from the ground truth.
Simulation
Data preparation
To show the utility of TEMT, we first carried out a ser-
ies of simulation studies. To obtain simulated read sets,
we used FluxSimulator [27], a software for transcrip-
tome and read generation by simulating the biochemical
processes underlying the library preparation. FluxSimu-
lator requires a reference transcript set to start the
simulation process, so we manually downloaded 406
transcripts of 208 alternatively spliced genes in human
from Alternative Splicing Structural Genomics Project
(AS3D) [28], and used these 406 transcripts as the refer-
ence transcript set. We first simulated the transcript
expression process twice producing two sets of relative
transcript abundances, corresponding to cell type a and
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b respectively. Based on these two transcript abundance
sets, we then simulated 6 pairs of 1 million 75-bp sin-
gle-end read sets corresponding to six different cell type
b proportions from 40% up to 90%. The relative tran-
script abundances of cell type a and b were kept the
same throughout these simulations. For each paired
read set, one read set is for the pure sample composed
of only cell type a, whereas the other read set is for the
mixed sample composed of both cell type a and b,
mixed with the cell type b proportion. Within the
mixed-sample read set, we also extracted the reads
simulated purely from cell type b, which was used for
control model eXpress.
Analysis
The simulated data are analyzed with the bias module
both enabled and disabled. Surprisingly, the positional
and sequence-specific bias module did not improve the
accuracy of the transcript abundance estimation as mea-
sured by the Error Fraction of estimated counts in both
TEMT and eXpress. This result may due to the stochas-
ticity during the simulation of FluxSimulator. So we
only present the results with the bias module disabled
in both TEMP and eXpress in Figure 2.
We note that the estimates of cell type a from TEMT
achieve roughly the same accuracy, compared with the
estimates from eXpress based on the read set of the
pure sample of cell type a. Also, this accuracy does not
change significantly under the effect of different cell
type b proportions. This is mainly due to the pure sam-
ple read set of cell type a within the input data for
TEMT.
The accuracy of the estimates of cell type b from
TEMT is also shown in Figure 2, which shows that
TEMT generally outperforms the direct estimation
method. To the best of our knowledge, there are no com-
putational tools similar to our model that can estimate
the relative transcript abundances of cell type b via RNA-
seq data generated from mixed samples. Typically, com-
putational methods are applied directly to the noisy data
of mixed samples and results are interpreted as the esti-
mates of cell type b. To compare the estimates of cell
type b from TEMT with direct estimates using the
Figure 2 Analysis results of simulated data of 6 different cell type b proportions with the bias module disabled. The x-axis is the
different cell type b proportion, and the y-axis is the Error Fraction of the corresponding estimates. The green and blue lines are the estimates
from TEMT for cell type a and cell type b, based on the two read sets of the cell type a pure sample and the mixed sample. The yellow and
magenta lines are the estimates from eXpress for cell type a and cell type b, based on the two read sets of the cell type a pure sample and the
cell type b pure sample. The red line is the direct estimates from eXpress for cell type b, based on the read set of the mixed sample.
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current method, we applied the control model eXpress
directly to the read set of the mixed sample. The esti-
mated counts from eXpress were then compared with
the true counts from another 1 million simulated read
set purely of cell type b, while keeping the same relative
transcript abundance as the previous simulations. The
corresponding Error Fractions are shown as the red line
in Figure 2 regarding different cell type b proportions.
Although the accuracy of cell type b estimates from
TEMT is affected by different cell type b proportions, it
is generally better than the direct estimates. This can be
further illustrated in Figure 3, which shows that the
direct estimated counts of cell type b from eXpress devi-
ate more from the true counts as the cell type b propor-
tion decrease, while the estimates of TEMT have much
reduced deviation. We notice that as the cell type b pro-
portion gradually decreases, the accuracy of the estimates
of cell type b from TEMT also decreases. This is the
result of the contamination effect from the cell type a
within the mixed sample. A recent paper [4] also
observed this similar phenomenon when studying copy
number aberrations from heterogeneous tumor tissue.
ENCODE data
Data preparation
Next we analyzed the recently released ENCODE data.
Due to the lack of RNA-seq data sampled from mixed
tissue samples with known cell type proportions, we
artificially generated the mixed-sample read sets by mix-
ing reads obtained from two different cell types. Specifi-
cally, we chose two Tier 1 cell lines, GM12878 and
K562, and treated them as cell type a and cell type b
respectively. The corresponding single-end RNA-seq
data of these two cell lines, GM78 1×75D A 1 (UCSC
Accession: wgEncodeEH000125) and K562 1×75D A 1
(UCSC Accession: wgEncodeEH000126) from the Wold
lab [29] at Caltech, were download from ENCODE
(2012). The data downloaded from the same lab under
similar protocols is intended to reduce the deviation
resulting from experiments. We then randomly selected
10 million reads from GM12878 cells to form the read
set of the pure sample, and 10 million reads from both
GM12878 and K562 cells using different K562 cells pro-
portions to form the read set of the mixed sample. Simi-
lar to the previous simulation study, we extracted the
Figure 3 Comparisons between indirect estimates from TEMT and direct estimates from eXpress for cell type b in terms of estimated
counts. The x-axis is the estimated counts from the two models, and the y-axis is the true counts. Each point in the figure is a comparison
between the estimated count and true count. The red points are the direct estimates from eXpress, while the blue points are the indirect
estimates from TEMT. Figure (a)-(f) are each comparison with cell type b proportions from 40% to 90%.
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reads purely selected from K562 cells within the mixed
sample, and used them for the eXpress control model.
We studied 6 different K562 cells proportions from 40%
to 90% in order to compare with the previous simula-
tion study. 36908 human RefSeq [30] transcripts from
UCSC known genes [31] were used as the transcript set
for the ENCODE data.
Analysis
One major issue in studying the ENCODE data is that
the ground truth of relative transcript abundance in
each cell type is unknown. We used the estimates from
eXpress based on the GM12878 and K562 pure samples
as the ground truth. Again, the bias module was dis-
abled for both TEMT and eXpress. The general result of
ENCODE data is shown in Figure 4. Similar to the
simulated data, the indirect estimates for K562 cells
from TEMT generally outperforms the direct estimates
from eXpress based on the read set of the mixed sam-
ple. The contamination effect from cell type a within
the mixed sample observed in Figure 3 is also seen in
the eXpress analysis of ENCODE data, while TEMT
does not have this issue. Note that the measure of
relative transcript abundances as shown in the red line
of Figure 4 is no longer estimated counts, but reads per
kilobase of transcript per million mapped reads
(RPKM), as the total number of reads from K562 cells
within the mixed sample is less than the total number
of reads of the mixed sample, so that normalization is
necessary for comparison. We notice TEMT underper-
forms direct estimates from eXpress when K562 cells
proportion equals 90%. Possibly the contamination effect
of GM12878 cells within the mixed sample is not severe
enough at this point, as we can imagine the red line in
Figure 4 will finally reach 0% Error Fraction when K562
cells proportion reaches 100%. On the other hand, since
the estimates from eXpress based on the pure sample
are considered the ground truth, the lower bound Error
Fraction of K562 cells estimates from TEMT should be
the same as the Error Fraction of GM12878 cells esti-
mates, which is around 20% to 30% in Figure 4.
Discussion
We formulated our model under the assumption that
the heterogeneous tissue is only composed of two cell
Figure 4 Analysis results of the ENCODE data of 6 different K562 cells proportions with the bias module disabled. The x-axis is the
different K562 cells proportions, and the y-axis is the Error Fraction of the corresponding estimates. The green and blue lines are the estimates
from TEMT for GM12878 and K562 cells, based on the read sets of the GM12878 cells pure sample and the mixed sample. The red line is the
direct estimates from eXpress for K562 cells, based on the read set of the mixed sample.
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types, but in reality, a heterogeneous tissue might be
much more complicated, consisting of multiple cell
types. To relax this constraint, our model needs to be
further extended to analyze more complex cases in
which each cell type may have its own subtypes, e.g.
breast cancer subtypes, leading to a more sophisticated
heterogeneous tissue environment. Further dissecting
cell subtype heterogeneity is the next step in refining
our model. Moving from two cell types to arbitrarily
many cell types is of great interest, since it may substan-
tially facilitate transcriptome study of heterogeneous
tissues.
One critical component necessary to make our model
work is the prior information of cell type b proportion,
which is necessary to resolve the identifiability problem of
mixed samples. In real experiments, precise prior informa-
tion regarding cell type proportions may be unavailable.
One solution in the context of our model is to down
weight the effect of the prior by decreasing the parameter
ba, bb, which adds more uncertainty to the cell mixture
proportion. However, this approach may decrease the per-
formance of the model as the uncertainty in cell mixture
proportion cannot be distinguished from the uncertainty
in transcript abundance estimation. This observation sug-
gests another direction to further improving our model
which is to solely estimate cell type b proportion without
the prior information. To fulfill this requirement, the iden-
tifiability problem needs to be resolved as mentioned in
section 2.3, which turns out to be comparatively hard for
RNA-seq data. Unlike the heterozygous and homozygous
deletions in [14], which can be utilized to differentiate
between the SNP array data generated by normal cells and
tumor cells, there are no such explicit differences between
the reads generated by distinct cell types in RNA-seq data,
thus making the generative mixture model unconstrained.
The “marker genes” method proposed by [11], which tries
to distinguish distinct cell types by utilizing genes uniquely
expressed in each cell type, provides a future potential
direction to extend the current model.
Conclusion
In this article, we propose a probabilistic model-based
method TEMT to estimate transcript abundance of indivi-
dual cell types based on RNA-seq data from heteroge-
neous tissue samples. TEMT utilizes prior information to
distinguish reads generated by each cell type within the
heterogeneous tissue sample. Positional and sequence-spe-
cific biases are also incorporated to improve estimation
accuracy. TEMT is able to process large datasets as the
online EM algorithm is adopted to guarantee a time com-
plexity proportional to the data size and a constant space
complexity. Our experiments on both simulated datasets
and ENCODE data shows that explicitly accounting for
tissue heterogeneity can significantly improve the accuracy
of transcript abundance estimation.
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